Bidirectional crosstalk via IL‐6, PGE2and PGD2between murine myofibroblasts and alternatively activated macrophages enhances anti‐inflammatory phenotype in both cells
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Background and Purpose: Alternatively activated macrophages (AAMs) are important cells in the resolution of inflammation and tissue repair. We examined the impact of myofibroblasts, a vital cell in wound healing and tissue repair, on the development and function of AAMs. Experimental Approach: The interaction between AAMs and myofibroblasts was tested using conditioned medium from murine dermal myofibroblasts and bone marrow‐derived macrophages. AAMs were differentiated with IL‐4 and IL‐13. Key Results: Conditioned medium from myofibroblasts enhanced the expression of AAM markers, arginase 1 and Ym1 (chitinase‐3‐like 3) and the spontaneous production of IL‐10, while suppressing LPS‐induced nitric oxide production. IL‐6 from the myofibroblasts contributed to the amplification of the AAM phenotype; the selective COX‐2 inhibitor, NS‐398, significantly reduced the ability of myofibroblasts to promote an AAM phenotype. Pharmacological analyses indicated that myofibroblast‐derived IL‐6 enhanced arginase activity and spontaneous IL‐10 output, while PGE 2, via the EP 4 receptor, enhanced arginase expression and LPS‐evoked IL‐10 production. PGD 2 suppressed LPS‐evoked nitric oxide via the DP 1 receptor. Reciprocally, conditioned medium from macrophages treated with IL‐4 + IL‐13 and myofibroblast conditioned medium components, but not macrophages given IL‐4 + IL‐13 only, reduced myofibroblast migration, the expression of COX‐2, and the production of PGE 2 and PGD 2. Conclusions and Implications: These findings define mechanisms by which myofibroblasts enhance an AAM phenotype, which can promote wound healing directly, and/or via feedback communication to the myofibroblast, subsequently down‐regulating its capacity to promote AAM function. This is an important homeostatic regulatory pathway in wound healing that can also limit unwanted fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212 · cited 2×
“…to be pro-inflammatory, but it can participate in the resolution of inflammation through mediation of the switch between neutrophil and monocyte recruitment (Scheller et al., 2011), and, in the context of tissue recovery, IL-6 / mice display defects in wound healing (Gallucci et al., 2000).”
BackgroundMonocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015 · cited 2×
“We opted to use a co-culture model composed of bone marrowderived macrophages and dermal fibroblasts as recruitment of bone marrow monocytes that differentiate into macrophages is important in wound healing (Shi and Pamer, 2011), and dermal fibroblasts are necessary for cutaneous wound healing (Bristic-Dujmovic et al.”
BackgroundMethodMacrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107 · cited 4×
“concentration range (Powell, 2003) to facilitate AAM polarization (Odegaard et al., 2007).”
BackgroundInfluentialMacrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392
McGrath, J. C., & Lilley, E. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12955 · Cited by 1,321
Fibroblasts in fibrosis: novel roles and mediators
Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082
Galli, S. J., Borregaard, N., & Wynn, T. A. (2011) · Nature Immunology · doi:10.1038/ni.2109 · Cited by 1,055
Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis
Pesce, J. T., Ramalingam, T. R., Mentink-Kane, M. M., Wilson, M. S., El Kasmi, K. C., Smith, A. M., Thompson, R. W., Cheever, A. W., Murray, P. J., & Wynn, T. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000371 · Cited by 816
Mauer, J., Chaurasia, B., Goldau, J., Vogt, M. C., Ruud, J., Nguyen, K. D., Theurich, S., Hausen, A. C., Schmitz, J., Brönneke, H. S., et al. (2014) · Nature Immunology · doi:10.1038/ni.2865 · Cited by 727 · cited 1×
“These findings are consistent with recombinant IL-6 promoting murine and human AAM phenotypes (Fernando et al., 2014; Mauer et al., 2014).”
ResultRole of nitric oxide in wound repair
Witte, M. B., & Barbul, A. (2002) · The American Journal of Surgery · doi:10.1016/s0002-9610(02)00815-2 · Cited by 556 · cited 2×
“NO produced by the constitutive NOS has important roles in wound healing (Witte and Barbul, 2002).”
BackgroundA Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18
Prasse, A., Pechkovsky, D. V., Toews, G. B., Jungraithmayr, W., Kollert, F., Goldmann, T., Vollmer, E., Müller-Quernheim, J., & Zissel, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1518oc · Cited by 497
Song, E., Ouyang, N., Hörbelt, M., Antus, B., Wang, M., & Exton, M. S. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1687 · Cited by 447
YlÖstalo, J. H., Bartosh, T. J., Coble, K., & Prockop, D. J. (2012) · STEM CELLS · doi:10.1002/stem.1191 · Cited by 427 · cited 3×
“…are major sources of PGs (Kendall and Feghali-Bostwick, 2014) that affect many aspects of macrophage biology and promote the development and/or function of regulatory macrophage subtypes (Kunkel et al., 1988; Heusinkveld et al., 2011; Ylöstalo et al., 2012; MacKenzie et al., 2013; Na et al., 2013).”
BackgroundKim, Y.-G., Udayanga, K. G. S., Totsuka, N., Weinberg, J. B., Núñez, G., & Shibuya, A. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2013.12.010 · Cited by 366
Barron, L., & Wynn, T. A. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00414.2010 · Cited by 304
Cited by
Macrophage and Fibroblast Interactions in Biomaterial‐Mediated Fibrosis
Witherel, C. E., Abebayehu, D., Barker, T. H., & Spiller, K. L. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801451 · Cited by 374
Myofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis
Tai, Y., Woods, E. L., Dally, J., Kong, D., Steadman, R., Moseley, R., & Midgley, A. C. (2021) · Biomolecules · doi:10.3390/biom11081095 · Cited by 240
“More recently, studies describing an array of functions and regulatory factors exhibited by myofibroblasts have suggested roles beyond wound contraction and scar formation, including macrophage-like phagocytosis [17], immunomodulation [18,19], and autophagy [20].”
BackgroundRegulation of extracellular matrix assembly and structure by hybrid M1/M2 macrophages
Witherel, C. E., Sao, K., Brisson, B. K., Han, B., Volk, S. W., Petrie, R. J., Han, L., & Spiller, K. L. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120667 · Cited by 212
Candela, M. E., Addison, M., Aird, R., Man, T.-Y., Cartwright, J. A., Ashmore-Harris, C., Kilpatrick, A. M., Starkey Lewis, P. J., Drape, A., Barnett, M., et al. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00393-3 · Cited by 11
Metadata
- Authors
- Fernando, M. R., Giembycz, M. A., & McKay, D. M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2016-02-08
- Volume
- 173
- Issue
- 5
- Pages
- 899-912
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2218774075
- Cited by
- 45
- References
- 15
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.